The tariff classification of Theophylline Extended-Release Tablets from Germany and Mirabegron Extended-Release Tablets from India
Reasoning
The tariff classification of Theophylline Extended-Release Tablets from Germany and Mirabegron Extended-Release Tablets from India
Cite this ruling
CBP Ruling N337124 (3004490060): The tariff classification of Theophylline Extended-Release Tablets from Germany and Mirabegron Extended-Release Tablets from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300449
The tariff classification of Metaraminol Bitartrate Injection USP in dosage form, from India
The tariff classification of Scopolamine Transdermal System from Australia and Pitavastatin Tablets from India
The tariff classification of Paroxetine Hydrochloride Tablets in dosage form, from India
The tariff classification of Colchicine Tablets in dosage form, from Italy
The tariff classification of Irinotecan Hydrochloride Injection in dosage form, from India